Cronos Group Jumps On Rumor Of Acquisition Talks With Curaleaf

Cronos Group (TSX: CRON) jumped as much as 20% in mid-day trading today following the release of a rumor by Reuters that the Altria Group (NYSE: MO) backed cannabis producer might be exploring a sale.

The exploration of a sale is said to follow the attraction of acquisition interest from peers in the industry, including Curaleaf Holdings (CSE: CURA). The company is said to be working with a financial advisor to examine the interest received from the multistate operator.

Both cannabis operators reportedly refused to comment on the rumor, while the source of the rumor requested anonymity due to the confidential nature of the discussions.

READ: Canopy Growth Gets Hit With Multiple $0.00 Price Targets

Whether an offer ultimately surfaces remains to be seen, with no mention being made of the price to be paid. At last count, Cronos had a market value of approximately C$972 million, although that has fluctuated since the report initially came out.

Cronos Group last traded at $2.70 on the TSX.


Information for this briefing was found via Reuters. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Begins Technical Studies For Permitting Bald Hill Antimony Project

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Related News

Curaleaf Holdings Announces Overnight Marketed Financing Following Democrat Sweep

At least one US multi-state operator is set to take advantage of the bullish sentiment...

Wednesday, January 6, 2021, 05:36:53 PM

Curaleaf Holdings Sees Revenues Climb 55% To $182.4 Million, Announces CEO Transition

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter financial results, reporting total revenue...

Tuesday, November 17, 2020, 04:39:50 PM

Curaleaf: Cormark Upgrades To Buy Rating, Canaccord, Haywood Raise Price Targets

After Curaleaf’s (CSE: CURA) record-breaking second-quarter numbers, analysts have upgraded their twelve-month price targets. Curaleaf...

Wednesday, August 19, 2020, 11:29:55 AM

Curaleaf Sees New Jersey Deny Renewal Of Adult Use License

Curaleaf (CSE: CURA) is reeling this morning after a decision by New Jersey’s Cannabis Regulator...

Friday, April 14, 2023, 08:11:39 AM

Cronos: Raymond James Reiterates Price Target After PharmaCann Investment

Yesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets...

Tuesday, June 15, 2021, 05:50:00 PM